Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
Uncertainty and Risk in HTA Decision Making
1 November 2016
The quality of decision-making in key public sector bodies dealing with resource allocation is a major determinant of their efficiency. One of the most difficult and contentious areas of decision-making is the way that uncertainty is dealt with.
Four Case Studies to Explore the Added Value of Oxford AHSN
9 January 2016
The Oxford Academic Health Science Network (Oxford AHSN) wishes to demonstrate the value of the various projects and programmes that the network has developed and implemented since it was established in 2013.
How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?
8 January 2016
This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting, Tokyo. The panel session was entitled “How…
“New Age” Decision Making in HTA: Is It Applicable in Asia?
1 August 2016
This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting in Tokyo. The panel session was entitled…
A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications
1 May 2016
NICE’s decisions exert an influence on the allocation of fixed NHS budgets, but decisions for different types of health interventions (for example drugs and devices) are…
Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
4 January 2016
This report details the views of a selection of experts in the fields of health and welfare economics on the cost-effectiveness threshold used by the National…
Assessing Trends in SMC Advice Decisions (October 2009- September 2015)
1 February 2016
The objective of this OHE Consulting Report was to outline trends in Scottish Medicines Committee (SMC) advice decisions for medicines for the period October 2009 to…
Cost-per-QALY in the US and Britain
28 December 2015
Professor Weinstein compares the use of cost-per-QALY approaches in the UK and the US. Britain has got it closer to right, but may go a little…
New OHE Publication: Model of Behaviour within Fuzzy Budget Constraints
23 December 2015
Recently published is a new OHE research paper entitled ‘Model of Behaviour within Fuzzy Budget Constraints’. The paper presents a model to capture the behaviour of…